Tdspharm
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Tdspharm develops and manufactures transdermal drug-delivery patches, adhesive patches applied to the skin that release medication steadily into the body, reducing side effects and improving patient convenience.
Listed on KOSDAQ, Korea's tech and small-cap board, it supplies pharmaceutical companies that market the finished products under their own brands, primarily through contract manufacturing arrangements. Its core business is concentrated in cataplasma (medicated gel patches) and plaster-type patches, and it is expanding its patch portfolio beyond anti-inflammatory pain relief into areas such as dementia, asthma, nicotine, and pain management.
Summary is AI-generated and may contain errors · figures from DART filings
The filing notes that virtually all commercially available transdermal patch products in Korea have been developed by foreign pharmaceutical companies, with no domestically originated products on the market.
Tdspharm in five facts
What does Tdspharm do?
Tdspharm develops and manufactures transdermal drug-delivery patches, adhesive patches applied to the skin that release medication steadily into the body, reducing side effects and improving patient convenience.
Where is Tdspharm listed and in which sector?
Tdspharm (Korean name: 티디에스팜) trades under KRX code 464280 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Health Care sector, Pharmaceuticals.
How large is Tdspharm?
Its market capitalisation was US$21.6M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Tdspharm's latest annual revenue and operating profit?
For fiscal year 2025, Tdspharm reported revenue of US$20.8M, operating profit of US$2.8M and net income of US$3.2M, per its annual report on DART (data retrieved from DART on 2026-10-02). Revenue was up 0.4% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-10-02
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.